vs
Bionano Genomics, Inc.（BNGO）与布鲁克（BRKR）财务数据对比。点击上方公司名可切换其他公司
布鲁克的季度营收约是Bionano Genomics, Inc.的122.9倍（$977.2M vs $8.0M）。布鲁克净利率更高（2.7% vs -99.8%，领先102.4%）。布鲁克同比增速更快（-0.2% vs -2.6%）。过去两年布鲁克的营收复合增速更高（16.4% vs -4.8%）
Bionano Genomics是一家基因组技术企业，开发并销售专有光学基因组测绘技术及相关诊断解决方案，可高精度检测基因组大型结构变异，服务全球学术研究机构、生物制药企业与临床诊断实验室，产品应用于肿瘤、罕见病研究等领域。
布鲁克公司是美国科学仪器制造商，总部位于马萨诸塞州比勒里卡，为公开上市企业。公司产品服务于分子与材料研究、工业及应用分析领域，旗下设有布鲁克科学仪器、布鲁克能源与超导技术（BEST）两大业务板块。
BNGO vs BRKR — 直观对比
营收规模更大
BRKR
是对方的122.9倍
$8.0M
营收增速更快
BRKR
高出2.4%
-2.6%
净利率更高
BRKR
高出102.4%
-99.8%
两年增速更快
BRKR
近两年复合增速
-4.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $8.0M | $977.2M |
| 净利润 | $-7.9M | $26.0M |
| 毛利率 | 42.8% | 46.0% |
| 营业利润率 | -107.4% | 7.8% |
| 净利率 | -99.8% | 2.7% |
| 营收同比 | -2.6% | -0.2% |
| 净利润同比 | 60.6% | 89.8% |
| 每股收益（稀释后） | $-0.12 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNGOBRKR
| Q4 25 | $8.0M | $977.2M | ||
| Q3 25 | $7.4M | $860.5M | ||
| Q2 25 | $6.7M | $797.4M | ||
| Q1 25 | $6.5M | $801.4M | ||
| Q4 24 | $8.2M | $979.6M | ||
| Q3 24 | $6.1M | $864.4M | ||
| Q2 24 | $7.8M | $800.7M | ||
| Q1 24 | $8.8M | $721.7M |
净利润BNGOBRKR
| Q4 25 | $-7.9M | $26.0M | ||
| Q3 25 | $-8.5M | $-59.6M | ||
| Q2 25 | $-6.9M | $7.6M | ||
| Q1 25 | $-3.1M | $17.4M | ||
| Q4 24 | $-20.1M | $13.7M | ||
| Q3 24 | $-44.2M | $40.9M | ||
| Q2 24 | $-16.2M | $7.6M | ||
| Q1 24 | $-31.4M | $50.9M |
毛利率BNGOBRKR
| Q4 25 | 42.8% | 46.0% | ||
| Q3 25 | 45.7% | 44.1% | ||
| Q2 25 | 51.6% | 44.9% | ||
| Q1 25 | 45.5% | 48.8% | ||
| Q4 24 | 41.9% | 50.4% | ||
| Q3 24 | -139.1% | 48.4% | ||
| Q2 24 | 33.3% | 48.0% | ||
| Q1 24 | 32.2% | 48.9% |
营业利润率BNGOBRKR
| Q4 25 | -107.4% | 7.8% | ||
| Q3 25 | -115.9% | -6.0% | ||
| Q2 25 | -115.8% | 1.5% | ||
| Q1 25 | -131.1% | 4.0% | ||
| Q4 24 | -146.3% | 7.4% | ||
| Q3 24 | -722.9% | 7.9% | ||
| Q2 24 | -219.0% | 6.0% | ||
| Q1 24 | -354.9% | 9.0% |
净利率BNGOBRKR
| Q4 25 | -99.8% | 2.7% | ||
| Q3 25 | -115.4% | -6.9% | ||
| Q2 25 | -101.8% | 1.0% | ||
| Q1 25 | -48.0% | 2.2% | ||
| Q4 24 | -246.5% | 1.4% | ||
| Q3 24 | -728.6% | 4.7% | ||
| Q2 24 | -208.8% | 0.9% | ||
| Q1 24 | -358.3% | 7.1% |
每股收益（稀释后）BNGOBRKR
| Q4 25 | $-0.12 | $0.10 | ||
| Q3 25 | $-1.59 | $-0.41 | ||
| Q2 25 | $-1.99 | $0.05 | ||
| Q1 25 | $-1.15 | $0.11 | ||
| Q4 24 | $-7.05 | $0.09 | ||
| Q3 24 | $-30.92 | $0.27 | ||
| Q2 24 | $-14.41 | $0.05 | ||
| Q1 24 | $-35.75 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $298.8M |
| 总债务越低越好 | — | $1.9B |
| 股东权益账面价值 | $44.4M | $2.5B |
| 总资产 | $73.6M | $6.2B |
| 负债/权益比越低杠杆越低 | — | 0.76× |
8季度趋势，按日历期对齐
现金及短期投资BNGOBRKR
| Q4 25 | $3.0M | $298.8M | ||
| Q3 25 | $3.1M | $293.1M | ||
| Q2 25 | $3.6M | $92.0M | ||
| Q1 25 | $3.6M | $184.2M | ||
| Q4 24 | $9.2M | $183.4M | ||
| Q3 24 | $8.8M | $148.1M | ||
| Q2 24 | $10.4M | $169.7M | ||
| Q1 24 | $15.8M | $340.1M |
总债务BNGOBRKR
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $1.4B |
股东权益BNGOBRKR
| Q4 25 | $44.4M | $2.5B | ||
| Q3 25 | $49.8M | $2.4B | ||
| Q2 25 | $45.4M | $1.8B | ||
| Q1 25 | $48.2M | $1.8B | ||
| Q4 24 | $35.4M | $1.8B | ||
| Q3 24 | $48.9M | $1.8B | ||
| Q2 24 | $80.3M | $1.8B | ||
| Q1 24 | $82.8M | $1.4B |
总资产BNGOBRKR
| Q4 25 | $73.6M | $6.2B | ||
| Q3 25 | $79.1M | $6.4B | ||
| Q2 25 | $76.0M | $6.3B | ||
| Q1 25 | $78.4M | $5.9B | ||
| Q4 24 | $76.7M | $5.8B | ||
| Q3 24 | $87.4M | $6.1B | ||
| Q2 24 | $129.4M | $5.9B | ||
| Q1 24 | $158.0M | $4.5B |
负债/权益比BNGOBRKR
| Q4 25 | — | 0.76× | ||
| Q3 25 | — | 0.83× | ||
| Q2 25 | — | 1.34× | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | 1.21× | ||
| Q1 24 | — | 0.97× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $229.8M |
| 自由现金流经营现金流 - 资本支出 | — | $207.2M |
| 自由现金流率自由现金流/营收 | — | 21.2% |
| 资本支出强度资本支出/营收 | — | 2.3% |
| 现金转化率经营现金流/净利润 | — | 8.84× |
| 过去12个月自由现金流最近4个季度 | — | $43.3M |
8季度趋势，按日历期对齐
经营现金流BNGOBRKR
| Q4 25 | $-4.2M | $229.8M | ||
| Q3 25 | $-5.9M | $-33.2M | ||
| Q2 25 | $-3.5M | $-127.5M | ||
| Q1 25 | $-2.8M | $65.0M | ||
| Q4 24 | $-6.5M | $190.0M | ||
| Q3 24 | $-13.3M | $38.4M | ||
| Q2 24 | $-21.0M | $1.1M | ||
| Q1 24 | $-28.1M | $21.8M |
自由现金流BNGOBRKR
| Q4 25 | — | $207.2M | ||
| Q3 25 | — | $-54.1M | ||
| Q2 25 | — | $-148.8M | ||
| Q1 25 | — | $39.0M | ||
| Q4 24 | — | $153.3M | ||
| Q3 24 | — | $5.8M | ||
| Q2 24 | — | $-23.5M | ||
| Q1 24 | — | $400.0K |
自由现金流率BNGOBRKR
| Q4 25 | — | 21.2% | ||
| Q3 25 | — | -6.3% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 4.9% | ||
| Q4 24 | — | 15.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | -2.9% | ||
| Q1 24 | — | 0.1% |
资本支出强度BNGOBRKR
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 2.4% | ||
| Q2 25 | — | 2.7% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 3.0% |
现金转化率BNGOBRKR
| Q4 25 | — | 8.84× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -16.78× | ||
| Q1 25 | — | 3.74× | ||
| Q4 24 | — | 13.87× | ||
| Q3 24 | — | 0.94× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.43× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BNGO
暂无分部数据
BRKR
| Bsi Nano | $309.1M | 32% |
| Bsi Biospin | $267.0M | 27% |
| Other | $179.9M | 18% |
| Transferred Over Time | $142.5M | 15% |
| Energy And Supercon Technologies | $69.5M | 7% |
